BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25881291)

  • 21. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease.
    Sun B; Zhou Y; Halabisky B; Lo I; Cho SH; Mueller-Steiner S; Devidze N; Wang X; Grubb A; Gan L
    Neuron; 2008 Oct; 60(2):247-57. PubMed ID: 18957217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin type 1a receptor deficiency decreases amyloid β-protein generation and ameliorates brain amyloid pathology.
    Liu J; Liu S; Matsumoto Y; Murakami S; Sugakawa Y; Kami A; Tanabe C; Maeda T; Michikawa M; Komano H; Zou K
    Sci Rep; 2015 Jul; 5():12059. PubMed ID: 26154270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synaptobrevin 1 mediates vesicle priming and evoked release in a subpopulation of hippocampal neurons.
    Zimmermann J; Trimbuch T; Rosenmund C
    J Neurophysiol; 2014 Sep; 112(6):1559-65. PubMed ID: 24944211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
    Gouras GK; Willén K; Faideau M
    Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
    Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
    Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.
    Cheng X; Wu J; Geng M; Xiong J
    Neurobiol Aging; 2014 Jun; 35(6):1217-32. PubMed ID: 24368087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Amyloid and α-synuclein cooperate to block SNARE-dependent vesicle fusion.
    Choi BK; Kim JY; Cha MY; Mook-Jung I; Shin YK; Lee NK
    Biochemistry; 2015 Mar; 54(9):1831-40. PubMed ID: 25714795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease.
    Yao XQ; Jiao SS; Saadipour K; Zeng F; Wang QH; Zhu C; Shen LL; Zeng GH; Liang CR; Wang J; Liu YH; Hou HY; Xu X; Su YP; Fan XT; Xiao HL; Lue LF; Zeng YQ; Giunta B; Zhong JH; Walker DG; Zhou HD; Tan J; Zhou XF; Wang YJ
    Mol Psychiatry; 2015 Nov; 20(11):1301-10. PubMed ID: 25917367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VAMP1 mutation causes dominant hereditary spastic ataxia in Newfoundland families.
    Bourassa CV; Meijer IA; Merner ND; Grewal KK; Stefanelli MG; Hodgkinson K; Ives EJ; Pryse-Phillips W; Jog M; Boycott K; Grimes DA; Goobie S; Leckey R; Dion PA; Rouleau GA
    Am J Hum Genet; 2012 Sep; 91(3):548-52. PubMed ID: 22958904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The intramembrane proteases SPPL2a and SPPL2b regulate the homeostasis of selected SNARE proteins.
    Ballin M; Griep W; Patel M; Karl M; Mentrup T; Rivera-Monroy J; Foo B; Schwappach B; Schröder B
    FEBS J; 2023 May; 290(9):2320-2337. PubMed ID: 36047592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rbfox1 Regulates Synaptic Transmission through the Inhibitory Neuron-Specific vSNARE Vamp1.
    Vuong CK; Wei W; Lee JA; Lin CH; Damianov A; de la Torre-Ubieta L; Halabi R; Otis KO; Martin KC; O'Dell TJ; Black DL
    Neuron; 2018 Apr; 98(1):127-141.e7. PubMed ID: 29621484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease and neuronal network activity.
    Gleichmann M; Mattson MP
    Neuromolecular Med; 2010 Mar; 12(1):44-7. PubMed ID: 19885650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA-15b contributes to depression-like behavior in mice by affecting synaptic protein levels and function in the nucleus accumbens.
    Guo L; Zhu Z; Wang G; Cui S; Shen M; Song Z; Wang JH
    J Biol Chem; 2020 May; 295(20):6831-6848. PubMed ID: 32209659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding the genetic and phenotypic spectrum of congenital myasthenic syndrome: new homozygous VAMP1 splicing variants in 2 novel individuals.
    Cotrina-Vinagre FJ; Rodríguez-García ME; Del Pozo-Filíu L; Hernández-Laín A; Arteche-López A; Morte B; Sevilla M; Pérez-Jurado LA; Quijada-Fraile P; Camacho A; Martínez-Azorín F
    J Hum Genet; 2024 May; 69(5):187-196. PubMed ID: 38355957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.